HomeProductCardiovascular & hematopoietic systemCardiovascular & hematopoietic system

NIFEHEXAL

NIFEHEXAL

Code : NIF04

Price: Contact

Manufacturer                          

  •       SANDOZ

Present/Packing          Nifehexal Retard extentab

                                      Nifehexal Retard 20 mg x 30's

                                      Nifehexal Retard 20 mg x 100's

Price                    

Features   

Delivery

 

 

Share this product to others

Shopping
guide
Add to cart

 
NIFEHEXAL

Manufacturer:

          Sandoz

Contents:

          Nifedipine

Indications:

          Listed in Dosage.

 

 

Contraindications:

 

          Acute MI, cardiogenic shock, acute unstable angina, treatment of anginal attack in chronic stable angina.

Special Precautions:

          Hypotension, poor cardiac reserve, heart failure (deterioration has been noted), severe aortic stenosis, hepatic impairment, DM, porphyric patients, pregnancy. Avoid abrupt withdrawal (associated with exacerbation of angina). Discontinue if with ischaemic pain following administration.

Dosage:

          Adult: PO HTN Extended release 10-40 mg twice daily or 20-90 mg once daily. Angina pectoris Extended release 10-40 mg twice daily or 30-90 mg once daily. Liquid-filled cap: 5-20 mg 3 times/day. Raynaud's syndrome Liquid-filled cap: 5-20 mg 3 times/day.

Class:

         Anti-Anginal Drugs / Calcium Antagonists

Presentation/Packing:

          Nifehexal Retard extentab

          Nifehexal Retard 20 mg x 30's
          Nifehexal Retard 20 mg x 100's
Details:

         

Nifedipine

Adult: PO HTN Extended release 10-40 mg twice daily or 20-90 mg once daily. Angina pectoris Extended release 10-40 mg twice daily or 30-90 mg once daily. Liquid-filled cap: 5-20 mg 3 times/day. Raynaud's syndrome Liquid-filled cap: 5-20 mg 3 times/day.

Updating

Hypotension, poor cardiac reserve, heart failure (deterioration has been noted), severe aortic stenosis, hepatic impairment, DM, porphyric patients, pregnancy. Avoid abrupt withdrawal (associated with exacerbation of angina). Discontinue if with ischaemic pain following administration.

Rating

(based on 0 rating)

We want to know your comment!


Write a review


     
  Rating
  Email *
  Fullname *
  Title *
  Content *
  Confirm code *